Discontinued — last reported Q2 '20
West Pharmaceutical Services Lease Liability Payments - Due Year Three decreased by 9.6% to $15.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.3%, from $16.00M to $15.00M. Over 3 years (FY 2020 to FY 2023), Lease Liability Payments - Due Year Three shows an upward trend with a 6.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Helps assess the company's long-term fixed obligation profile and future cash flow requirements.
The projected cash payments for operating and finance leases scheduled for the third year following the balance sheet da...
Standard disclosure for lease maturity profiles.
lease_liability_payments_due_year_3| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.70M | $8.50M | $10.00M | $9.40M | $9.70M | $12.80M | $16.00M | $13.40M | $13.80M | $14.10M | $11.20M | $11.90M | $15.30M | $15.50M | $16.00M | $16.70M | $16.60M | $15.00M |
| QoQ Change | — | -2.3% | +17.6% | -6.0% | +3.2% | +32.0% | +25.0% | -16.3% | +3.0% | +2.2% | -20.6% | +6.3% | +28.6% | +1.3% | +3.2% | +4.4% | -0.6% | -9.6% |
| YoY Change | — | — | — | — | +11.5% | +50.6% | +60.0% | +42.6% | +42.3% | +10.2% | -30.0% | -11.2% | +10.9% | +9.9% | +34.5% | +9.2% | +7.1% | -6.3% |